Vitamin D Therapy Market Report 2026

Vitamin D Therapy Market Overview

• Vitamin D Therapy market size has reached to $3.24 billion in 2025 • Expected to grow to $6.05 billion in 2030 at a compound annual growth rate (CAGR) of 13.4% • Growth Driver: The Surge In Vitamin D Therapy Market Fueled By The Rising Prevalence Of Malnutrition • Market Trend: Strategic Partnerships Enhancing Market Position in Vitamin D Therapy • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Vitamin D Therapy Market?

Vitamin D therapy refers to supplements that are commonly used to treat and prevent vitamin D deficiency. Vitamin D therapy helps regulate calcium and phosphorus in the body. It also plays a role in maintaining proper bone structure. Vitamin D supplementation may help people with depression who also have a vitamin D deficiency. The administration involved in vitamin D therapy are oral and parenteral. Oral refers to entering the body through the mouth. The various purchasing involved are OTC drugs and prescription drugs that are used by various age groups such as by children, adults, and senior citizens for osteoporosis, rickets, skin diseases, muscle weakness, and autoimmune disorder applications.

What Is The Vitamin D Therapy Market Growth Forecast?

The vitamin d therapy market size is expected to see rapid growth in the next few years. It will grow to $6.05 billion in 2030 at a compound annual growth rate (CAGR) of 13.4%. The growth in the forecast period can be attributed to advancements in personalized nutrition, integration of vitamin d in functional foods, growth in preventive healthcare, increasing government initiatives for micronutrient supplementation, rise in chronic disease management. Major trends in the forecast period include personalized vitamin d supplementation, fortified food and beverage integration, growing awareness of vitamin d deficiency, increased focus on bone health and immunity, rise in home healthcare solutions.

Global Vitamin D Therapy Market Segmentation

1) By Administration: Oral, Parenteral 2) By Purchasing: OTC Drugs, Prescription Drugs 3) By Age Group: Children, Adults, Senior Adults 4) By Application: Osteoporosis, Rickets, Skin Diseases, Muscle Weakness, Autoimmune Disorders Subsegments: 1) By Oral: Vitamin D3 Supplements (Cholecalciferol), Vitamin D2 Supplements (Ergocalciferol), Vitamin D Fortified Foods And Beverages 2) By Parenteral: Injectable Vitamin D3 (Cholecalciferol), Injectable Vitamin D2 (Ergocalciferol), Intravenous Vitamin D Preparations

What Are The Drivers Of The Vitamin D Therapy Market?

An increased prevalence of malnutrition cases is expected to propel the growth of the vitamin D therapy market going forward. Malnutrition refers to deficiencies or excesses in nutrient intake, imbalances of essential nutrients, or impaired nutrient utilization. Vitamin D deficiency is highly prevalent in the population of malnourished inpatients and is negatively associated with long-term mortality, particularly when patients are not receiving vitamin D treatment. Thus, the increased prevalence of malnutrition cases creates demand for vitamin D therapy. For instance, in August 2025, according to UNICEF, a US-based United Nations agency, reported that more than 251.7 million children under 5 were screened for wasting in 64 countries, exceeding the target of 200 million; of these, more than 9.3 million children with severe wasting were admitted for life-saving treatment. Therefore, the increasing prevalence of malnutrition cases is driving the growth of the vitamin D therapy industry. Increasing prevalence of chronic diseases is expected to propel the demand for the vitamin D therapy market going forward. Chronic disease is ongoing, progresses, and usually gets worse over time if no lifestyle adjustments are undertaken. Alzheimer's disease, rheumatoid arthritis, Parkinson's disease, and cancer are all examples of chronic diseases. Vitamin D therapy plays a crucial role in managing chronic diseases by addressing the associated complications and supporting overall health. Numerous studies highlight the link between vitamin D deficiency and an increased risk of chronic conditions such as cardiovascular diseases, diabetes, and certain cancers. Adequate vitamin D levels contribute to immune system regulation, cardiovascular health, and metabolic function. Individuals with chronic diseases often exhibit lower levels of vitamin D, and supplementation is recognized as a valuable adjunct in their management. For instance, in May 2024, according to National Cancer Institute (NCI), a US-based federal government's principal agency for cancer research and training. In 2024, an estimated 2,001,140 new cases of cancer will be diagnosed in the United States and 611,720 people will die from the cancer. Prostate, lung, and colorectal cancers account for an estimated 48% of all cancers diagnosed in men in 2024. For women, the three most common cancers are breast, lung, and colorectal, and they will account for an estimated 51% of all new cancer diagnoses in women in 2024. The number of cancer survivors is projected to increase to 22.5 million by 2032. Therefore, increasing chronic diseases are driving the growth of the vitamin D therapy industry.

Key Players In The Global Vitamin D Therapy Market

Major companies operating in the vitamin d therapy market are Abbott Laboratories, Sanofi SA, GlaxoSmithKline PLC, Pfizer Inc., Merck & Co Inc., Torrent Pharmaceuticals Ltd., Novartis International AG, Alkem Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cadila Healthcare Ltd., Biotics Research Corporation, Solvay Pharma India Pvt. Ltd., Forgo Pharmaceuticals Ltd., Mankind Pharmaceuticals Pvt. Ltd., Cipla Ltd., Ortho Molecular Products, Zhejiang Garden Biochemical High-tech Co. Ltd., Glenmark Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd., Emcure Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Lupin Ltd., Macleods Pharmaceuticals Ltd., Mylan N.V., Teva Pharmaceutical Industries Ltd., Biocare Medical LLC, Mitsubishi Chemical Group, Zydus Cadila, DSM Nutritional Products AG, BASF SE, Fermenta Biotech Ltd., Taizhou Hisound Pharmaceutical Co. Ltd.

Global Vitamin D Therapy Market Trends and Insights

Major companies operating in in the vitamin D therapy market are get into partnerships to strengthen their position in the market. A business strategic partnership refers to a structured affiliation between two or more commercial enterprises, typically established via one or more business agreements or contracts. For instance, in July 2024, Catalyst Pharmaceuticals, Inc. Ltd., a US-based pharmaceutical company entered into a License, Supply, and Commercialization Agreement with Kye Pharmaceuticals Inc, a Canada-based pharmaceutical company, granted Kye the exclusive Canadian commercial rights to AGAMREE (vamorolone). Vamorolone is used to treat Duchenne muscular dystrophy (DMD), due to deficiency of vitamin.

Regional Insights

North America was the largest region in the vitamin D therapy market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Vitamin D Therapy Market?

The vitamin D therapy market consists of sales of plain vitamin D therapy and active vitamin D analog (or D-hormone) therapy. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Vitamin D Therapy Market Report 2026?

The vitamin d therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the vitamin d therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.